Important Note: Please join wikispaces (it's free!) so that you can participate in discussions.

OTC References: Active Ingredients and Monographs

[29-Sept-2009]

Active ingredients by name

Active Ingredients by category

TERMINOLOGY UPDATES

[11-Feb-2009]

The following two new section headings are now acceptable in SPL documents:

OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION

The section headings and associated LOINC codes are located here: http://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/ucm162057.htm


Special Events
None currently scheduled


Objective: Address questions and concerns regarding SPL that affect the OTC industry.

Leader: Vacant

Contact mhoward@chpa.org to join this group.

No Meeting/Teleconference schedule (calls scheduled as needed)

Next meeting:
TBD





2015 Call Summary Notes:

Call Date
Summary Notes
14 September 2015



2011 Call Summary Notes:
Call Date
Summary Notes
12 September 2011

13 June 2011

11 April 2011

14 March 2011

14 February 2011

2010 Call Summary Notes:
Call Date
Summary Notes
13 December 2010

13 September 2010



12 July 2010

8 March 2010





Training Materials (not all inclusive):

Training Materials from SPL R4 Overview & Training - Over-the-Counter Drug Products (July 30, 2008):




Training Materials from SPL R4 Overview & Training - Over-the-Counter Drug Products (June 26, 2009)



Training Materials from SPL R4 Overview & Training - Over-the Counter Drug Products (July 8, 2009)



Training Materials from SPL R4 Training - Common Errors in SPL R4 Submissions (July 8, 2009)



OTC SPL Template* (Posted July 15, 2009)
*Note: Fictitious product label created by Pryia Samuel, CHPA



Instructions for viewing the file:

1. Copy zip file to location on computer.

2. Unzip the file

3. Open the SPL file



Vendor Presentations:

The vendor presentations are provided as educational opportunities only and do not reflect any endorsement or recommendation by the SPL OTC Sub-team, SPL Process Team, SPL Leadership Team, or the FDA.


Additional Information:

SPL Updates: Join FDA Data Standards Council's listserv. To join, select this link Sign up for email updates on this web page: http://www.fda.gov/ForIndustry/DataStandards/default.htm.


FDA Electronic Submissions Gateway: http://www.fda.gov/ForIndustry/ElectronicSubmissionsGateway/default.htm


Links to SPL R4 Electronic Drug Establishment Registration and Drug Listing documents: http://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/default.htm (see heading entitled "SPL Guidance and Supporting Documents.")


Question-and-Answer Document - Please view respective Discussion Pages for responses. New questions and issues to Marcia Howard, Paula Markert, and Devon Morgan for posting consideration.




Section headings and LOINC codes for OTC content:
50569-3
OTC - ASK DOCTOR SECTION
50568-5
OTC - ASK DOCTOR/PHARMACIST SECTION
50570-1
OTC - DO NOT USE SECTION
50565-1
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
53414-9
OTC - PREGNANCY OR BREAST FEEDING SECTION
53413-1
OTC - QUESTIONS SECTION
50566-9
OTC - STOP USE SECTION
50567-7
OTC - WHEN USING SECTION


Question


What LOINC code should be used for an Ingredients Section?

Answer


The LOINC code for DESCRIPTION can be used for the Ingredients Section in an OTC label.



See FDA SPL Resources Page for the complete list of section LOINC codes and other terminologies.

Vendor Presentations and 2008, 2009 Call Summary docs